Dehydro Olmesartan Medoxomil is a pharmaceutical impurity related to the antihypertensive drug olmesartan medoxomil. It is characterized as a structural derivative containing an imidazole ring and a tetrazole moiety, with a molecular weight of approximately 540 g/mol and moderate lipophilicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 879562-26-2
Olmesartan medoxomil
pharmaceutical raw material
7,7'-[Butane-1,4-diylbis(oxy)]di(3,4-dihydroquinolin-2(1H)-one)
pharmaceutical raw material
1-benzoyl-2-(1-methylhexahydro-1H-azepin-4-yl)diazane
pharmaceutical raw material
Chloroxylenol
pharmaceutical raw material
N-adamantylacetamide
pharmaceutical raw material
Cefepime
pharmaceutical raw material
Pilsicainide hydrochloride
pharmaceutical raw material
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2-yl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
PSFJJUXSEHXDFN-UHFFFAOYSA-N
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(=C)C